Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hikari Heights-Varus Co's enterprise value is 円-3,121 Mil.
Hikari Heights-Varus Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円-205 Mil. Therefore, Hikari Heights-Varus Co's EV-to-EBITDA for today is 15.20.
The historical rank and industry rank for Hikari Heights-Varus Co's EV-to-EBITDA or its related term are showing as below:
SSE:2137'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -28.98 Med: -12.7 Max: 21.48
Current: 15.2
During the past 13 years, the highest EV-to-EBITDA of Hikari Heights-Varus Co was 21.48. The lowest was -28.98. And the median was -12.70.
SSE:2137's EV-to-EBITDA is ranked worse than 65.24% of 515
companies
in the Healthcare Providers & Services industry
Industry Median: 10.72
vs SSE:2137: 15.20
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hikari Heights-Varus Co (SSE:2137) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hikari Heights-Varus Co's PE Ratio (TTM) for today is calculated as:
Hikari Heights-Varus Co's share price for today is 円720.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hikari Heights-Varus Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-151.110.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSE:2137 vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Hikari Heights-Varus Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hikari Heights-Varus Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hikari Heights-Varus Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hikari Heights-Varus Co's EV-to-EBITDA falls into.
Hikari Heights-Varus Co's current Enterprise Value is 円-3,121 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hikari Heights-Varus Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was 円-205 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hikari Heights-Varus Co (SSE:2137) has a EV-to-EBITDA of 15.20 as of Aug. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hikari Heights-Varus Co. According to the industry distribution chart, Hikari Heights-Varus Co ranks #336 out of 515 companies in the Healthcare Providers & Services industry, placing it in the top 65.2%.
Is Hikari Heights-Varus Co's EV-to-EBITDA too high?
Hikari Heights-Varus Co's current EV-to-EBITDA is 15.20. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.72. Hikari Heights-Varus Co's value of 15.20 is 41.8% above this industry median. Based on the distribution chart, Hikari Heights-Varus Co ranks #336 out of 515 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Hikari Heights-Varus Co has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hikari Heights-Varus Co's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hikari Heights-Varus Co ranks #336 out of 515 companies for EV-to-EBITDA. This places Hikari Heights-Varus Co in the lower half of its industry. The industry median EV-to-EBITDA is 10.72. Hikari Heights-Varus Co's value of 15.20 is 41.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.72, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hikari Heights-Varus Co's current EV-to-EBITDA of 15.20 is 41.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Hikari Heights-Varus Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hikari Heights-Varus Co's current EV-to-EBITDA is 15.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikari Heights-Varus Co stock overvalued right now?
Based on GuruFocus' analysis, Hikari Heights-Varus Co (SSE:2137) is currently considered Fairly Valued. The stock's GF Value™ is 円730.22, compared to a current price of 円720.00 — trading 1.4% below its estimated fair value. The current EV-to-EBITDA is 15.20 and 41.8% above the Healthcare Providers & Services industry median of 10.72. Hikari Heights-Varus Co's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Hikari Heights-Varus Co (SSE:2137), the current EV-to-EBITDA is 15.20 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hikari Heights-Varus Co (SSE:2137) Overvalued in 2026?
Based on GuruFocus' analysis, Hikari Heights-Varus Co stock appears to be undervalued.
The current stock price of 円720.00 is trading 1.4% below its estimated GF Value™ of 円730.22.
GuruFocus considers Hikari Heights-Varus Co to be Fairly Valued.
Key valuation signals for SSE:2137:
EV-to-EBITDA: 15.20
GF Value™: 円730.22 vs. price of 円720.00 (1.4% below fair value)
Industry Position: 41.8% above the Healthcare Providers & Services median (#336 of 515)
No single metric tells the full story. See the SSE:2137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hikari Heights-Varus Co Ltd is a Japanese firm engaged in operating senior homes. It operates nursing homes for the elderly. The company provides rooms for healthy elderly as well as ones requiring assisted living.
51GF Score
Get the complete analysis for SSE:2137
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSE:2137 has been successfully added to your 
